Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Centene ( (CNC) ).
Centene Corporation announced its participation in the Deutsche Bank 2025 Healthcare Summit on September 11, 2025, where management will discuss the company’s business and financial results through August. The results align with its full-year 2025 forecast of approximately $1.75 adjusted diluted earnings per share. The company emphasizes the use of non-GAAP financial measures to provide investors with a clearer view of its core operations, although it cautions that these measures may differ from those used by other companies.
The most recent analyst rating on (CNC) stock is a Hold with a $33.00 price target. To see the full list of analyst forecasts on Centene stock, see the CNC Stock Forecast page.
Spark’s Take on CNC Stock
According to Spark, TipRanks’ AI Analyst, CNC is a Neutral.
Centene’s overall score is driven by strong revenue growth and a stable balance sheet. However, low operational margins and significant challenges highlighted in the earnings call weigh on the score. The stock’s bearish technical indicators and lack of dividend yield further limit its appeal.
To see Spark’s full report on CNC stock, click here.
More about Centene
Centene Corporation operates in the healthcare industry, providing a range of services primarily focused on government-sponsored healthcare programs. The company is known for its managed care services and has a significant presence in the Medicaid, Medicare, and Health Insurance Marketplace sectors.
Average Trading Volume: 16,660,819
Technical Sentiment Signal: Sell
Current Market Cap: $15.36B
For a thorough assessment of CNC stock, go to TipRanks’ Stock Analysis page.